Sign in
Home
Services
Blog
News
Investment
Investment Plans
Insurance Policy
Write For Us
Stock Market Terms
Quiz
NISM-Series-VIII: Equity Derivatives Mock Test Part – 1
NISM-Series-VIII: Equity Derivatives Mock Test Part 2
Analysis
Buy Books
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Search here...
Search
Home
Services
Blog
News
Investment
Investment Plans
Insurance Policy
Write For Us
Stock Market Terms
Quiz
NISM-Series-VIII: Equity Derivatives Mock Test Part – 1
NISM-Series-VIII: Equity Derivatives Mock Test Part 2
Analysis
Buy Books
More
Home
Services
Blog
News
Investment
Investment Plans
Insurance Policy
Write For Us
Stock Market Terms
Quiz
NISM-Series-VIII: Equity Derivatives Mock Test Part – 1
NISM-Series-VIII: Equity Derivatives Mock Test Part 2
Analysis
Buy Books
Search here...
Search
Tag:
debt
ERIS Lifesciences: Smart Investment or Hidden Red Flags?
Analysis
StockIsy
-
27 March, 2025
ERIS Lifesciences Ltd: Growth or Red Flags? 🤔📈 A significant momentum is visible in an important pharmaceutical stock—ERIS Lifesciences Ltd! 🚀 Some aspects appear positive,...
Vodafone Idea’s Bold Expansion Claim: Reality or Just a Marketing Gimmick?
Analysis
StockIsy
-
23 March, 2025
Vodafone Idea (Vi) is once again seeking government support to tackle its AGR (Adjusted Gross Revenue) and spectrum dues. At the same time, the...
Red Flags in Gensol Engineering Ltd! 🚩🚩
Analysis
StockIsy
-
19 March, 2025
The biggest concern here is that the company's market capitalization is INR 900 crore, while its debt has surged to INR 1372 crore. This...
Is Godrej Consumer Products Overvalued?
Analysis
StockIsy
-
18 March, 2025
Godrej Consumer Products has a market cap of ₹1,06,393 crore, but its financials do not look particularly strong. If we analyze its valuation, the...
I want in
I've read and accept the
Privacy Policy
.
KEC International: A Global EPC Powerhouse Driving Infrastructure Growth Across Sectors
StockIsy
-
5 August, 2025
Read more
ITD Cementation Set for Strong FY26 on Robust Order Pipeline and Adani Synergy
Analysis
Piramal Pharma: A Re-Emerging Pharma Player with Strong Growth Ambitions
Equity Research Report
Cement Sector Consolidation: Ambuja Acquires Majority Stake in Orient Cement
Equity Research Report
Mankind Pharma Levels Up: ₹12,000 Cr Revenue, ₹8,500 Cr Debt – What’s the Strategy?
Equity Research Report
India’s Economy in 2025: Stable, Strong, and Strategically Positioned
Blog
Contact Form
Your Name (required)
Your Email (required)
Your Number
Subject
Your Message
Δ
CLOSE